Curis(CRIS) - 2022 Q4 - Earnings Call Transcript

Curis, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Conference Call March 13, 2023 8:30 AM ET Conference Call Participants Operator Diantha Duvall James Dentzer We've also made important progress in our work to resolve the partial clinical hold on our leukemia study. In last quarter's call, we announced that the FDA had approved the reopening of our clinical sites so that we could enroll nine additional patients at the 200-milligram dose level to facilitate discussions with FDA on the Recommended Phase 2 Dose or RP2 ...